Purchase Order 75N92020P00006

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $597,605.36 on September 10, 2018, for BD FACSymphony trade-in and purchase. The order has no small business set-aside. Performance is located in San Jose, California. The ultimate completion date is February 28, 2019. The originating opportunity was posted as a special notice on August 30, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $38,127.60 on August 30, 2019, for BD Biosciences FACSAria maintenance agreement services, with ultimate completion on August 29, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...

The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at one hundred sixty-five thousand five hundred seventeen dollars and thirteen cents ($165,517.13) to Becton, Dickinson and Company for a BD FACSymphony A1 cell analyzer. Becton, Dickinson and Company will deliver the requested cell analyzer as the prime contractor. No set-aside designation was used for this award. Performance will occur at Sparks Glencoe, Maryland by...

<p>The National Heart, Lung, and Blood Institute (NHLBI) awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $17,550.00 on June 2, 2026, for service contract support of a BD Symphony A1 flow cytometer. Performance is at Framingham, Massachusetts. The order is firm fixed price with a completion date of June 1, 2027. No small business set-aside applies.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) valued at $192,240.00 on July 3, 2020, for maintenance services on a government-owned BD FACSymphony A5 flow cytometer. Work is performed in Bethesda, Maryland. The requirement covers preventive maintenance and technical support for the laboratory instrument. Ultimate completion was July 2, 2025. The purchase order originated from a...

The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on November 20, 2015, with a ceiling value of $15,413.40 for service contract support related to BD FACSCanto flow cytometry instrumentation. The order ran from October 1, 2015, through September 30, 2016, at the place of performance in Bethesda, MD. Pricing was firm fixed price with no set-aside applied. The order was issued on a full-and-open basis to the...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on December 20, 2016, with a ceiling value of $29,795.40 for maintenance services. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. Ultimate completion date is January 31, 2018.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...